UHS Chemotherapy Adjuvant

Read full text Summarise with VIRAT
Authors: V
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Novel Macromolecular Targeted Chemoprotective PreparationThis breakthrough macromolecular agent is engineered for systemic protection and efficacy enhancement during solid tumor chemotherapy. Versatile Delivery: Supports oral administration (crosses the gastrointestinal barrier, bypassing hepatic first-pass degradation), IV, and subcutaneous injection. Clinical Indications: Specifically antagonizes chemotherapy-induced toxicities in parenchymal organs (cardiac, hepatorenal, auditory), repairs the blood-brain barrier to alleviate neuropathy, and arrests bone marrow senescence to mitigate severe suppression. Dual Mechanism: * Healthy Tissue Shield: Provides spatial isolation and neutralizes free radicals to protect normal cells. - Microenvironment Remodeling: Inhibits cancer stem cell metabolism and lifts immunosuppression without compromising chemotherapeutic lethality. Core Advantages: Features high specificity with minimal off-target rates and stable pharmacokinetics. The molecular conformation is robust, supporting high-temperature sterilization and long-term cold-chain storage with excellent multi-drug compatibility.Currently seeking co-development with pharmaceutical companies.E-mail: research@laplacedemon-lab.com

Fields of Study & Subjects

Chemotherapy-induced organ toxicity mitigation Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 March 2026
Language
EN
Document type
Dataset